Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Ironwood Pharmaceuticals Inc
Ironwood Pharmaceuticals Inc_20100114
  

Ironwood Pharmaceuticals Inc patents

Recent patent applications related to Ironwood Pharmaceuticals Inc. Ironwood Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Ironwood Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Ironwood Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "I" | Ironwood Pharmaceuticals Inc-related inventors




Date Ironwood Pharmaceuticals Inc patents (updated weekly) - BOOKMARK this page
09/21/17 new patent  Gastro-retentive sustained-release oral dosage form of a bile acid sequestrant
06/08/17Low-dose stable formulations of linaclotide
06/01/17Imidazotriazinone compounds
05/18/17Sgc stimulators
05/18/17Sgc stimulators
04/27/17Sgc stimulators
03/09/17Sgc stimulators
12/29/16Sgc stimulators
12/01/16Sgc stimulators
11/10/16Use of sgc stimulators for the treatment of neuromuscular disorders
10/27/16Delayed release compositions of linaclotide
10/27/16Low-dose stable formulations of linaclotide
10/27/16Sgc stimulators
07/28/16Treatments for disorders using guanylate cyclase c agonists
07/28/16Treatments for disorders using guanylate cyclase c agonists
07/21/16Treatment of constipation-predominant irritable bowel syndrome
06/30/16Salts, co-crystals, and polymorphs of an anxiolytic compound
06/23/16Sgc stimulators
06/16/16Methods and compositions for the treatment of gastrointestinal disorders
02/25/16Compositions comprising bile acid sequestrants for treating esophageal disorders
02/04/16Sgc stimulators
01/21/16Gastro-retentive sustained-release oral dosage form of a bile acid sequestrant
12/03/152-benzyl, 3-(pyrimidin-2-yl) substituted pyrazoles useful as sgc stimulators
09/10/15Sgc stimulators
08/20/15Sgc stimulators
06/25/15Faah inhibitors
05/14/15Stable solid formulation of a gc-c receptor agonist polypeptide suitable for oral administration
04/30/15Treatments for gastrointestinal disorders
04/02/15Treatments for gastrointestinal disorders
04/02/15Treatments for gastrointestinal disorders
03/19/15Methods of treating alopecia and acne
01/29/15Treatments for gastrointestinal disorders
01/29/15Orally disintegrating compositions of linaclotide
01/15/152-benzyl, 3-(pyrimidin-2-yl) substituted pyrazoles useful as sgc stimulators
12/25/14Stable formulations of linaclotide
11/27/14Treatments for gastrointestinal disorders
11/27/14Treatment of chronic constipation
11/20/14Treatments for gastrointestinal disorders
11/06/14Methods and compositions for the treatment of gastrointestinal disorders
10/30/14Sgc stimulators
10/30/14Treatments for gastrointestinal disorders
10/02/14Methods and compositions for the treatment of gastrointestinal disorders
09/11/14Treatments for gastrointestinal disorders
07/03/14Crth2 modulators and preparation thereof
06/26/14Treatments for gastrointestinal disorders
06/12/14Treatment of constipation-predominant irritable bowel syndrome
04/17/14Compositions and methods for treating or preventing gastrointestinal disorders and gerd-related respiratory disorders
03/27/14Sgc stimulators
01/23/14Treatments of gastrointestinal disorders
01/02/14Treatments of gastrointestinal disorders
12/19/13Methods and compositions for the treatment of gastrointestinal disorders
10/03/13Crth2 modulators
08/29/13Use of faah inhibitors for treating abdominal, visceral and pelvic pain
08/22/13Crth2 modulators
08/01/13Cannabinoid receptor agonists
07/25/13Formulations comprising linaclotide
07/11/13Cannabinoid agonists
07/11/13Sgc stimulators
06/20/13Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
05/23/13Treatments for gastrointestinal disorders
05/23/13Compositions and methods for treating or preventing gastrointestinal disorders and gerd-related respiratory disorders
05/16/13Soluble guanylate cyclase (sgc) modulators for treatment of lipid related disorders
05/02/13Faah inhibitors
04/04/13Treatments for gastrointestinal disorders
02/21/13Method for modulating the pharmacodynamic effect of orally administered guanylate cyclase receptor agonists
Patent Packs
01/31/13Cb receptor agonists
11/08/12Methods and compositions for the treatment of gastrointestinal disorders
08/23/12Stable solid formulation of a gc-c receptor agonist polypeptide suitable for oral administration
08/02/12Methods and compositions for the treatment of gastrointestinal disorders
07/05/12Methods and compositions for the treatment of gastrointestinal disorders
06/14/12Selenophene and selenazole carboxylic acid derivatives
05/03/12Methods and compositions for the treatment of gastrointestinal disorders
04/12/12Methods and compositions for the treatment of gastrointestinal disorders
02/16/12Stable solid formulations of gc-c receptor agonist polypeptides suitable for oral administration
01/12/12Stable solid formulation of therapeutic polypeptides suitable for oral administration
12/22/11Crth2 modulators
12/22/11Pyrrolopyridine carboxylic acid derivatives
12/15/11Protein expression methods
11/10/11Selenophene and selenazole carboxylic acid derivatives
06/30/11Compositions and methods of use for treating or preventing lipid related disorders
Patent Packs
06/02/11Compositions and methods for treating or preventing gastrointestinal disorders and gerd-related respiratory disorders
05/26/11Methods and compositions for the treatment of gastrointestinal disorders
05/19/11Treatments of gastrointestinal disorders
05/19/11Methods and compositions for the treatment of gastrointestinal disorders
12/09/10Compositions and methods for reducing the toxicity of certain toxins
09/16/10Methods and compositions for the treatment of gastrointestinal disorders
06/10/10Soluble guanylate cyclase (sgc) modulators for treatment of lipid related disorders
02/25/10Stable solid formulation of a gc-c receptor agonist polypeptide suitable for oral administration
01/14/10Pharmaceutical formulation for parenteral administration
12/17/09Compositions and methods for treating nonalcoholic fatty liver disease-associated disorders
12/10/09Methods and composition for the treatment of gastrointestinal disorders
11/26/09Organometal benzenephosphonate coupling agents
09/17/09Methods and compositions for the treatment of gastrointestinal disorders
02/26/09Compositions and methods of use for treating or preventing lipid related disorders
01/14/10Pharmaceutical formulation for parenteral administration







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Ironwood Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Ironwood Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';